top of page

XILONIBSA Solution for Injection 2% 1:80000

Product details

Registration number: SIN14157P

Classification: Prescription Only

Active ingredients:

  • Adrenaline tartrate 0.02274mg/ml eqv Adrenaline
  • Lidocaine hydrochloride

Strength:

  • 0.0125mg/ml
  • 20.00mg/ml

Dosage form: INJECTION, SOLUTION

Route: SUBMUCOSAL

Registrant: FONDACO PTE LTD

ATC code: N01BB52

HSA approval date: 11 June 2012

Manufacturer(s): Laboratorios Inibsa, S.A.

Manufacturing country/countries: SPAIN

What are the HSA registration number and classification for XILONIBSA Solution for Injection 2% 1:80000?

According to the HSA dataset updated 7 August 2026:

Registration number: SIN14157P

Classification: Prescription Only

Source for this answer

What active ingredients and strength are recorded for XILONIBSA Solution for Injection 2% 1:80000?

According to the HSA dataset updated 7 August 2026:

Active ingredients:

  • Adrenaline tartrate 0.02274mg/ml eqv Adrenaline
  • Lidocaine hydrochloride

Strength:

  • 0.0125mg/ml
  • 20.00mg/ml

Ingredients and strengths are listed separately as recorded by HSA; their positions do not establish a one-to-one match. This is not a dosing instruction.

Source for this answer

What dosage form and route are recorded for XILONIBSA Solution for Injection 2% 1:80000?

According to the HSA dataset updated 7 August 2026:

Dosage form: INJECTION, SOLUTION

Route: SUBMUCOSAL

Source for this answer

Who is the recorded registrant for XILONIBSA Solution for Injection 2% 1:80000?

According to the HSA dataset updated 7 August 2026:

Registrant: FONDACO PTE LTD

Source for this answer

Which manufacturers and countries are listed for XILONIBSA Solution for Injection 2% 1:80000?

According to the HSA dataset updated 7 August 2026:

Manufacturer(s): Laboratorios Inibsa, S.A.

Manufacturing country/countries: SPAIN

Source for this answer

Where can I look up XILONIBSA Solution for Injection 2% 1:80000 in the HSA register?

Open HSA’s therapeutic product register and search for registration number SIN14157P or the exact product name XILONIBSA Solution for Injection 2% 1:80000. The general register link does not preselect this product.

Source for this answer

What are the source dates for this XILONIBSA Solution for Injection 2% 1:80000 record?

This record is from HSA’s List of Registered Therapeutic Products on data.gov.sg. Dataset update: 7 August 2026. Retrieval date: 13 November 2026.

The dataset date is a snapshot date, not a separate current-register check for every product. Later direct checks are recorded separately.

Source for this answer

Has this XILONIBSA Solution for Injection 2% 1:80000 record had a separate HSA register check?

No separate current-register check is recorded for this product. Its presence in the imported dataset does not establish its current registration status.

Search the HSA register using SIN14157P for the latest record.

Source for this answer

Sources and dates

HSA dataset: 2026. Updated: 13 November 2026.

Factual product information only; no dosing, treatment or suitability advice.

Updated and reviewed by: Dr Joel Lim MBChB UK (PG Dip Dermatology), Resident Physician.

bottom of page